약물 남용 검사 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Drugs of Abuse Testing Market size is expected to reach USD 2.60 Billion in 2034 from USD 1.62 Billion (2025) growing at a CAGR of 5.38% during 2026-2034.

The Global Drugs of Abuse Testing Market is expanding significantly due to increasing substance abuse cases and strict regulatory policies worldwide. Governments and organizations are implementing mandatory workplace drug testing to ensure safety and compliance. The growing prevalence of opioid addiction and rising awareness regarding drug misuse are contributing to the market's steady growth across healthcare, law enforcement, and corporate sectors.

Major growth drivers include technological advancements in rapid testing kits, immunoassay analyzers, and laboratory-based confirmation methods. Increasing adoption of point-of-care testing devices has improved efficiency and reduced turnaround time. Additionally, expanding roadside drug testing programs and rising investments in toxicology laboratories are fueling market expansion in developed and developing regions alike.

Future prospects remain strong as digital integration and portable testing devices become more advanced and affordable. The expansion of rehabilitation centers and stricter anti-drug regulations will further boost demand. Emerging markets are expected to present significant opportunities due to improving healthcare infrastructure and awareness campaigns. Overall, consistent policy support and technological innovation will sustain long-term market growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Drug Type

• Psychostimulants
• Narcotics
• Cannabinoids
• Sedatives
• Others

By Technique Type

• Immunoassay
• Chromatography
• Rapid Testing

By End User

• Hospitals
• Diagnostics Laboratories
• Forensic Laboratories
• Others

COMPANIES PROFILED

• Abbott Laboratories Alere Inc, F Hoffmann LaRoche Ltd, Siemens AG Siemens Healthineers, Thermo Fisher Scientific Inc, Drgerwerk AG Co KGaA, Chromsystems Instruments Chemicals GmbH, AccuBioTech Co Ltd, Screen Italia Srl, Paramedical srl, MP Biomedicals
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL DRUGS OF ABUSE TESTING MARKET: BY DRUG TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Drug Type
• 4.2. Psychostimulants Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Narcotics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Cannabinoids Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Sedatives Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL DRUGS OF ABUSE TESTING MARKET: BY TECHNIQUE TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Technique Type
• 5.2. Immunoassay Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Chromatography Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Rapid Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL DRUGS OF ABUSE TESTING MARKET: BY END USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End User
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Diagnostics Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Forensic Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL DRUGS OF ABUSE TESTING MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Drug Type
  • 7.2.2 By Technique Type
  • 7.2.3 By End User
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Drug Type
  • 7.3.2 By Technique Type
  • 7.3.3 By End User
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Drug Type
  • 7.4.2 By Technique Type
  • 7.4.3 By End User
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Drug Type
  • 7.5.2 By Technique Type
  • 7.5.3 By End User
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Drug Type
  • 7.6.2 By Technique Type
  • 7.6.3 By End User
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL DRUGS OF ABUSE TESTING INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Abbott Laboratories (Alere Inc.)
  • 9.2.2 F. Hoffmann La-Roche Ltd
  • 9.2.3 Siemens AG (Siemens Healthineers)
  • 9.2.4 Thermo Fisher Scientific Inc
  • 9.2.5 Drgerwerk AG Co KGaA
  • 9.2.6 Chromsystems Instruments & Chemicals GmbH
  • 9.2.7 AccuBioTech Co. Ltd
  • 9.2.8 Screen Italia Srl
  • 9.2.9 Paramedical S.R.L
  • 9.2.10 MP Biomedicals